Study on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Volunteers
Status:
Completed
Trial end date:
2022-04-08
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of multiple doses of YK-1169 in healthy subjects, the
pharmacokinetic characteristics of multiple doses in healthy subjects, and the drug
interaction between cefepime and avibactam.